Formulation and acoustic studies of a new phase-shift agent for diagnostic and therapeutic ultrasound.


Recent efforts in the area of acoustic droplet vaporization with the objective of designing extravascular ultrasound contrast agents has led to the development of stabilized, lipid-encapsulated nanodroplets of the highly volatile compound decafluorobutane (DFB). We developed two methods of generating DFB droplets, the first of which involves condensing DFB… (More)
DOI: 10.1021/la2013705


10 Figures and Tables